AzTrials
AzTrials

Professional FulfillmentNCT06742047

A Professional Development Programme (ProDeveloP) for Newly Graduated Nurses

A study testing Professional development programme in people with Professional Fulfillment and Professional Identity Formation, run by Mälardalen University at 1 site in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This clinical study aims to implement and evaluate a professional development programme (ProDeveloP) designed to facilitate the transition of newly graduated nurses (NGNs) into their new roles. NGNs face several challenges in the work environment and in developing their professional competencies. Read more about this study

Who is it for?
Ages 20 to 65 yearsHealthy volunteers can take part
What is being tested?
Professional development programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
101 participants
Where
1 siteSweden
Study dates
27 Nov 2022to 1 Oct 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Registered nurses in Sweden employed as Newly Graduated Nurses (NGNs) in a county in central Sweden participating in the ProDeveloP, the intervention group.
  • Registered nurses in Sweden employed as Newly Graduated Nurses (NGNs) in a county in central Sweden, NGNs participating in the introduction programme prior to the study, not participating in the ProDeveloP, the control group.
  • Experienced registered nurses as facilitators for the dialogue groups for the NGNs in the intervention.
  • Managers at the county hospital for the NGNs participating in the intervention.

Who cannot join

  • Managers without NGNs participated in the intervention.

Trial locations and contacts

1 site in 1 country.

Sweden1 site
  • Mälardalens University

    Västerås, 721 23

Other trials in Sweden

About this study

Official title: Implementing a Professional Development Programme (ProDeveloP): an Introduction for Newly Graduated Nurses

This clinical study aims to implement and evaluate a professional development programme (ProDeveloP) designed to facilitate the transition of newly graduated nurses (NGNs) into their new roles. NGNs face several challenges in the work environment and in developing their professional competencies. The aim is to support NGNs in a county hospital in central Sweden to facilitate their professional development. Data will be collected during the NGNs' first year through measures at week week 13 (for both arms) and quarterly (intervention grpoup). This will be combined with individual interviews and focus groups with NGNs, dialogue facilitators and managers.

Read the detailed description

The primary outcomes will be role clarity, task mastery, social acceptance, recovery and stress. The researchers will compare the results of the primary outcomes with those of a control group measure. Secondary outcomes will be experience of the intervention, transition support, job satisfaction and intention to leave.

Informed consent was signed prior to participation in the study. The ethical application has been approved by the Ethics Authority IS, diary number 2022-05682-0.

Being tested
Professional development programme
Keywords
Introduction programme, Newly graduated nurses, Professional development, Role clarity, Task mastery, Stress, Recovery, Reflection, Social acceptance, Transition support, Dialogue group, Registered nurse, Focus group, Intervention, Interview, Intensive measures
Medical subject headings
Social Identification

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Professional development programmeBehavioural

    The professional development programme include dialogue groups facilitated by registered nurses (RN) who are expert and experienced supervisors that received a three day training before conducting the groups. Then including education days with joint lectures and simulations with experts in the field with experience. The programme provides NGNs with regular opportunities for reflection for learning from experiences of care to enhance personal and professional growth.

Study groups in NCT06742047
Study groupRoleWhat they receive
Participating in the Professional development program (ProDeveloP)ExperimentalThe group received the intervention of the Professional Development Programme (ProDeveloP). The planning of the ProDeveloP has been done in close collaboration with stakeholders within the hospital setting where the programme will be implemented. The programme includes face-to-face approaches from peer learning and e-learning modalities.
Receives: Behavioral: Professional development programme
Control group prior the intervention in 2022No interventionThe group did not receive the intervention but participated in the prior introduction programme in 2022 including 8 educational days.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Role Clarity

    Role clarity, the professional development process in terms of gaining clarity about the responsibilities content and boundaries of the role, was measured with the Validated scale from the Questionnaire for Psychological and Social Factors at Work (QPS Nordic).

    A 5-point Likert scale was used with three items.

    During the last week, how did you feel about:

    1. Having clearly defined goals?
    2. You know what your responsibilities are?
    3. You know exactly what is required of you at work? These items range from 'Very seldom or never (0)' to 'Very often or always' (4). The items were summed to between 0-12. Higher summed scores indicated better outcomes.

    Measured: The measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.

  2. Task Mastery

    Task mastery was measured with the validated scale from Swedish version of the Needs Satisfaction and Frustration Scale (NSFS).

    A 5-point Likert scale was used with two items.

    1. During the last week, have you felt that you have been able to fulfil even the most demanding tasks?
    2. During the last week, have you felt that you have been good at doing your job? These items range from 'Very seldom or never (0)' to 'Very often or always' (4). The items were summed to between 0-8. Higher summed scores indicated better outcomes.

    Measured: The measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.

  3. Social Acceptance

    Social acceptance, of being integrated into the work group and belonging at work, was measured with the validated Needs Satisfaction and Frustration Scale (NSFS).

    A 5-point Likert scale was used with two items. During the last week: I have felt that the people I work with have really cared about me? I have felt included in the work group?A 5-point lickert scale was used.

    These items range from 'Very seldom or never (0)' to 'Very often or always' (4). The items were summed to between 0-8. Higher summed scores indicated better outcomes.

    Measured: The measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.

  4. Stress

    Stress levels was measured with the validated Stress and Energy Questionnaire (SEQ).

    A 5-point Likert scale was used with three items.

    During the last week when you have been working, how often have you felt:

    1. Tense?
    2. Stressed?
    3. Pressured? These items range from 'Very seldom or never (0)' to 'Very often or always' (4). The items were summed to between 0-12. Lower summed scores indicated better outcomes.

    Measured: The measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.

Secondary outcomes (3)
  1. Job Satiscation

    Job satisfaction was measrued validated Job Satisfaction scale with 5-point lickert scale with three items.

    How often do you feel about your work in the following ways

    1. I feel happy at work?
    2. I feel satisfied with the work I have?
    3. I feel satisfaction with my work? Range from 'Very seldom or never´(0) och 'Very often or often´ (4). Summed items to between 0-12. Higher scores better outcomes.

    Measured: Measured during months 4, 8 and 12 after enrollment of the intervention. No control group measurements are available for the secondary outcomes.

  2. Intentions to Leave

    Intentions to leave the workplace or profession was measured by the validated Organizational Commitment on Job Turnover Intention scale.

    Please respond to the following statements about changing workplace:

    1. I often think about leaving my current place of work?
    2. As sson as possible I will leave my current workplace?
    3. I am actively looking for a job outside my current workplace?

    Please comment on the following statements about changing profession:

    1. I often think about changing profession?
    2. I actively look for work outside this profession?
    3. I would like to leave this profession as soon as possible? Using a 7-point Likert scale with a range of 'completely incorrrect´ (0) to'completely correct´ (6).

    Measured: Measured during months 4, 8 and 12 after enrollment of the intervention. No control group measurements are available for the secondary outcomes.

  3. Recovery

    Recovery was measured by the validated Karolinska Sleep Questionnaireith 5-point Likert scale ranging from "not at all" to "very much".

    The Sleep quality of 3 items from the subjective meaning of good sleep from:

    1. Did you have trouble falling asleep last night? 2. How did you sleep last night? 3. Have you slept restlessly? 2 item of being able to let go of work thoughts
    2. During the past week, have I had difficulty letting go of thoughts about work during my free time?
    3. During the past week, have you been able to relax? 1 items engagement in leisure activities scale of using a 5-point Lickert scale ranging from "never" to "daily".
    4. During the past week, have you been able to do activities that give you energy?

    Measured: Measured during months 4, 8 and 12 after enrollment of the intervention. No control group measurements are available for the secondary outcomes.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2024
  2. Study start27 Nov 2022
  3. Primary completion17 Sep 2024
  4. Study completion1 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Two cohorts of NGNs received the ProDevelop intervention in 2023 and 2024. A control group in 2022 did not receive the intervention but the previous introduction programme.
Masking
None (open label)
Enrolment
101 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06742047
Sponsor's protocol ID
220065
Status last verified
Feb 2026
First submitted
18 Dec 2024
Last updated
18 Mar 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The ethical approval do not allow to share IPD outside the research group.

Publications

  • Lindblom M, Widarsson M, Sodersved Kallestedt ML, Letterstal A, Nilsson KW, Asp M, Hoglander J. Associations Between Participation in ProDeveloP and Newly Graduated Nurses' Stress and Professional Development When Transitioning into Practice. SAGE Open Nurs. 2026 Feb 9;12:23779608261421265. doi: 10.1177/23779608261421265. eCollection 2026 Jan-Dec.

    PubMed 41675920
  • Lindblom M, Hoglander J, Letterstal A, Sodersved Kallestedt ML, Asp M, Widarsson M. Reflection Supports Newly Graduated Nurses' Professional Development When Transitioning Into Practice. J Clin Nurs. 2025 Jul;34(7):2948-2960. doi: 10.1111/jocn.17772. Epub 2025 Apr 10.

    PubMed 40207698
  • Hoglander J, Lindblom M, Sodersved Kallestedt ML, Letterstal A, Asp M, Widarsson M. Implementing a Professional Development Programme (ProDeveloP) for Newly Graduated Nurses: A Study Protocol. Nurs Rep. 2025 Jul 2;15(7):243. doi: 10.3390/nursrep15070243.

    PubMed 40710938

Questions about this trial

What is this clinical trial studying?

A study testing Professional development programme in people with Professional Fulfillment and Professional Identity Formation, run by Mälardalen University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 18 Mar 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Role Clarity (time frame: The measurement was collected at one time point at thirteen weeks of participation in the ProDeveloP for the intervention group or in the prior introduction programme for the control group.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06742047, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in